Johnson & Johnson to showcase electrophysiology portfolio at HRS meeting

Johnson & Johnson will showcase the latest advances across its electrophysiology portfolio at the 2026 Heart Rhythm Society Annual Meeting, including new evidence in pulsed field ablation, and innovations in cardiac mapping and imaging. At HRS 2026, the company will launch the CARTOSOUND SONATA Module, leveraging artificial intelligence with the CARTO System to automatically transform intracardiac echocardiography images into detailed maps, allowing physicians to build accurate models of multiple heart chambers.The module also enables identification and automatic labeling of cardiac structures. CARTOSOUND SONATA seamlessly integrates with both SOUNDSTAR CRYSTAL and NUVISION NAV ultrasound cathetersiv, enabling physicians to plan and perform treatment across a range of heart rhythm conditions, including atrial fibrillation, ventricular tachycardia, and complex concomitant procedures. At HRS 2026, Johnson & Johnson will present new clinical and real-world data on the VARIPULSE Platform for atrial fibrillation, highlighting safety, workflow efficiency, and real-world patient outcomes. Fully integrated with the CARTO System, VARIPULSE delivers precise, efficient, and reproducible treatment outcomes. In the U.S., the latest VARIPULSE Plus update introduces automated irrigation flow control, reinforcing the platform’s safety profile and supporting procedural consistency and physician confidence. Building on this advancement, the company recently launched the VARIPULSE Pro3 platform in Europe with a new pulse sequence to streamline procedures and enhance workflow efficiency.